To promote brain health and help people reduce their risk of dementia.
Early detection of cognitive decline is a crucial part of the healthcare pathway for individuals with Alzheimer’s disease and Alzheimer’s disease-related dementias (AD/ADRD). Identifying impairment in its earliest stages can help us know what underlying cause of cognitive decline may be and whether it can be treated. Treatment options can include (a) pharmacological treatments, such as medications that target specific brain diseases or that help alleviate symptoms of cognitive decline; or (b) non-pharmacological treatments, such as lifestyle interventions that promote brain health by addressing cardiometabolic disease, or cognitive rehabilitation programs to help people compensate for memory loss.
We partnered with local community organizations to conduct cognitive screenings in over 300 older adults living in Central Ohio to examine the associations among cognitive function, attitudes about participating in research, and social determinants of health.
Enrollment for this study is now closed.
We are conducting digital cognitive screenings at health fairs across Central Ohio to examine the extent to which cardiovascular health is associated with cognitive health in adults and older adults.
This study will be launching soon!
Black Impact is a 6-month, randomized controlled, multidomain lifestyle intervention designed to improve cardiovascular health in Black men. Black Impact: Brain Health is an ancillary study examining how changes in cardiovascular health are associated with cognitive health in Black men.
Enrollment for this study is now closed.
Food & Fitness with Medicine is a 6-month, randomized controlled, multidomain lifestyle intervention examining cardiovascular-kidney-metabolic (CKM) syndrome and cognitive health in postmenopausal women who have recently begun taking GLP-1 receptor agonist medications.